Citi analyst Yigal Nochomovitz lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Wedbush Assumes Ultragenyx Pharma (RARE) at OutperformAugust 2, 2019 7:29 AM Ultragenyx Pharma (RARE) PT Lowered to $80 at SVB LeerinkAugust 2, 2019 7:18 AM Ultragenyx Pharma (RARE) PT Lowered to $87 at BarclaysAugust 2, 2019 6:29 AM Form 10-Q Ultragenyx Pharmaceutica For: Jun 30August 2, 2019 6:03 AM Ultragenyx Pharma (RARE) Misses Q2 EPS by 2c, Revenues BeatAugust 1, 2019 5:39 PM Form 8-K Ultragenyx Pharmaceutica For: Aug 01August 1, 2019 4:07 PM Ultragenyx Reports Second Quarter 2019 Financial Results and Corporate UpdateAugust 1, 2019 4:02 PM Ultragenyx Reports Second Quarter 2019 Financial Results and Corporate UpdateAugust 1, 2019 4:01 PM Form 8-K Ultragenyx Pharmaceutica For: Aug 01August 1, 2019 8:36 AM Ultragenyx Pharma (RARE) Announces Submission of NDA to FDA for UX007 (triheptanoin) for Treatment of Long-Chain Fatty Acid Oxidation DisordersAugust 1, 2019 8:31 AM